Drugs Rules Amendment Brings Stem Cell, Gene Therapy & Xenograft Products Under CLAA Licensing Regime

Regulatory change extends the Cosmetic, Licences, Advertisements and Approvals framework to three advanced therapy categories, closing a classification gap and triggering new licence and approval requirements for manufacturers and importers.

bt-corporate · 7/2/2026, 1:32:32 PM · Ask about this →